VRTX Vertex Pharmaceuticals Incorporated
Healthcare
Price
$530.97
Intrinsic value
$181.21
Buy price
$144.97
Discount
-193.0%
DCF walkthrough
Near-term growth (g1)10.35%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
- Operating CF
- $4,292,900,000.00
- Total debt
- $1,977,600,000.00
- Cash & STI
- $7,852,400,128.00
- Shares out.
- 255,200,000
Overvalued
Intrinsic value$181.21
Buy price (with MOS)$144.97
Current price$530.97
Discount to intrinsic value-193.0%
7-step quality scorecard
ROE quality
HIGH_VOLATILE- Average ROE
- 15.6%
- Current ROE
- 21.2%
- Minimum ROE
- -3.3%
Debt quality
CONSERVATIVE- Debt / Equity
- 0.11x
Moat proxy
WEAK_PROXYCash-flow reliability
OK- Operating CF / Net income
- 0.97x
Technical chart
Confluence: NONE (0/3)Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim.
Assumptions & data quality
- Data source
- yfinance
- Growth (g1) source
- revenueCAGR
- Valuation model
- DCF_OCF
- Debt as % of DCF PV
- 4.9%
- Public economic interest
- 100.0%
These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.